analysis of the association between X-ray cross-complementing gene 1 (XRCC1) genetic polymorphism Arg399Gln and esophageal cancer (EC) risk. Statistical analysis was performed with the Review Manager version
distinct rates throughout carcinogenesis process. This differentiated expression may contribute in the genetic regulation of many cancers, including gastrointestinal ones. The mission of let-7 in the gastrointestinal…
recent findings on how genetic differences impact the metabolism, effectiveness, and safety of cancer treatments. Key genetic markers, such as polymorphisms in drug-metabolizing enzymes (e.g., CYP450, UGT1A1) and drug…
Breast cancer is a complex and heterogeneous disease influenced by genetic and epigenetic factors that regulate tumor initiation, progression, and response to therapy. Genetic alterations, including mutations in…
treatment options. Recent advancements in genomic research have uncovered a wealth of genetic variants associated with ovarian cancer susceptibility, shedding light on the underlying molecular mechanisms driving disease…
pivotal tool in oncology, facilitating personalized treatment approaches by identifying specific genetic mutations that drive cancer development and progression. This article explores the implications of genetic testing…
genetic and epigenetic factors contributing to cancer development. Understanding the roles of genetics and epigenetics in cancer is crucial for devising effective diagnostic and therapeutic strategies. This article…
Cytokine gene transfer stands as a promising frontier in cancer therapy, harnessing the genetic machinery to empower the immune system in its battle against malignancies. This abstract delves into
delves into the intricate relationship between polyunsaturated fatty acids (PUFAs) and cancer risk, with a focus on the genetic factors that underlie this association. PUFAs, essential components of the human ... diet…